BeOne Medicines (ONC) News Today $295.59 +3.66 (+1.25%) As of 07/22/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock ONC Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period BeOne Medicines (NASDAQ:ONC) Sets New 52-Week High After Analyst UpgradeJuly 19, 2025 | americanbankingnews.comThe S&P 500 and Nasdaq Are Joined By These Stocks Hitting New HighsJuly 18, 2025 | msn.comJPMorgan Chase & Co. Forecasts Strong Price Appreciation for BeOne Medicines (NASDAQ:ONC) StockJuly 18, 2025 | marketbeat.comBeOne Medicines (NASDAQ:ONC) Price Target Raised to $349.00July 18, 2025 | americanbankingnews.comBeOne Medicines (NASDAQ:ONC) Hits New 52-Week High on Analyst UpgradeJuly 17, 2025 | marketbeat.comLooming Tariffs Don't Scare This Swiss Cancer Treatment StockJuly 16, 2025 | msn.comRoyal Bank Of Canada Increases BeOne Medicines (NASDAQ:ONC) Price Target to $349.00July 16, 2025 | marketbeat.comBeOne Medicines to Announce Second Quarter 2025 Financial Results on August 6July 16, 2025 | businesswire.comBeOne Medicines (NASDAQ:ONC) Shares Gap Up - Here's WhyJuly 15, 2025 | marketbeat.comBeOne Medicines (NASDAQ:ONC) Rating Lowered to Hold at Wall Street ZenJuly 14, 2025 | americanbankingnews.comBiocytogen Enters into Antibody Licensing Agreement with BeOne ...July 13, 2025 | businesswire.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) CEO John Oyler Sells 27,802 SharesJuly 12, 2025 | insidertrades.comBeOne Medicines (NASDAQ:ONC) Cut to Hold at Wall Street ZenJuly 12, 2025 | marketbeat.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) CEO Sells $7,044,470.76 in StockJuly 11, 2025 | marketbeat.comBeOne Medicines Ltd. American Depositary Shares (ONC) Insider ActivityJuly 11, 2025 | nasdaq.comBrokerages Set BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) Price Target at $320.67July 11, 2025 | americanbankingnews.comEuropean Commission Approves TEVIMBRA® in Combination with Chemotherapy as a First-Line Treatment for Nasopharyngeal CarcinomaJuly 10, 2025 | businesswire.comBiocytogen Enters into Antibody Licensing Agreement with BeOne Medicines to Accelerate Innovative Drug DevelopmentJuly 9, 2025 | businesswire.comBiocytogen Enters into Antibody Licensing Agreement with BeOne Medicines to Accelerate Innovative Drug DevelopmentJuly 9, 2025 | businesswire.comONC BeOne Medicines Ltd. - Seeking AlphaJuly 8, 2025 | seekingalpha.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) Receives Consensus Rating of "Buy" from BrokeragesJuly 8, 2025 | marketbeat.comThis Startup Built A Hospital In India To Test Its AI SoftwareJuly 2, 2025 | forbes.comBeOne Medicines (NASDAQ:ONC) Shares Gap Down - Time to Sell?June 27, 2025 | marketbeat.comMorgan Stanley Forecasts Strong Price Appreciation for BeOne Medicines (NASDAQ:ONC) StockJune 27, 2025 | marketbeat.comBeOne Medicines (NASDAQ:ONC) Price Target Raised to $321.00June 27, 2025 | marketbeat.comBeOne Medicines (NASDAQ:ONC) Receives "Outperform" Rating from Royal Bank Of CanadaJune 27, 2025 | marketbeat.comBeOne Medicines Ltd.: BeOne Medicines to Host Investor R&D Day Webcast on June 26, 2025 - FinanzNachrichten.deJune 26, 2025 | finanznachrichten.deBeOne Medicines (NASDAQ:ONC) Stock Price Down 3.6% on Insider SellingJune 26, 2025 | marketbeat.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) Insider Lai Wang Sells 1,028 SharesJune 26, 2025 | insidertrades.comLai Wang Sells 1,028 Shares of BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) StockJune 25, 2025 | marketbeat.comInsider Selling: BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) COO Sells 1,363 Shares of StockJune 25, 2025 | marketbeat.comInsider Selling: BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) Insider Sells 2,007 Shares of StockJune 25, 2025 | marketbeat.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) CEO Sells $830,350.14 in StockJune 25, 2025 | marketbeat.comBeOne Medicines Receives Positive CHMP Opinion for Tablet Formulation of BRUKINSA®June 25, 2025 | businesswire.comGlenmark Pharma Launches Lung Cancer Treatment Drug After Approval From AuthoritiesJune 24, 2025 | msn.comBeOne Medicines (NASDAQ:ONC) Shares Gap Up - What's Next?June 23, 2025 | marketbeat.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) SVP Chan Henry Lee Sells 422 SharesJune 19, 2025 | insidertrades.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) Insider Sells $118,143.90 in StockJune 18, 2025 | marketbeat.comInsider Selling: BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) COO Sells 630 Shares of StockJune 18, 2025 | marketbeat.comInsider Selling: BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) Insider Sells 1,177 Shares of StockJune 18, 2025 | marketbeat.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) CEO Sells $374,475.40 in StockJune 18, 2025 | marketbeat.comInsider Selling: BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) COO Sells 1,543 Shares of StockJune 18, 2025 | marketbeat.comJohn Oyler Sells 3,680 Shares of BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) StockJune 18, 2025 | marketbeat.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) SVP Chan Henry Lee Sells 422 SharesJune 18, 2025 | marketbeat.comBeigene (NASDAQ:ONC) Stock Price Down 5.4% - Should You Sell?June 17, 2025 | marketbeat.comBeigene (NASDAQ:ONC) Shares Gap Down - What's Next?June 16, 2025 | marketbeat.comBeigene, Ltd. (NASDAQ:ONC) Insider Sells $34,620.24 in StockJune 13, 2025 | insidertrades.comBeigene, Ltd. (NASDAQ:ONC) Receives Consensus Rating of "Buy" from AnalystsJune 13, 2025 | marketbeat.comBeigene, Ltd. (NASDAQ:ONC) Insider Sells $34,620.24 in StockJune 12, 2025 | marketbeat.comBeigene, Ltd. (NASDAQ:ONC) Insider Sells $10,975,363.20 in StockJune 12, 2025 | marketbeat.com Get BeOne Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter. Email Address ONC Media Mentions By Week ONC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONC News Sentiment▼0.530.59▲Average Medical News Sentiment ONC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONC Articles This Week▼117▲ONC Articles Average Week Get BeOne Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SNY News GSK News TAK News ARGX News BNTX News SMMT News INSM News TEVA News GMAB News MRNA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ONC) was last updated on 7/23/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BeOne Medicines Ltd. - Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share BeOne Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
